Virulence and attenuation of murine cytomegalovirus

J E Osborn1, D L Walker

  • 1Departments of Pediatrics and Medical Microbiology, University of Wisconsin Medical School, Madison, Wisconsin 53706.

Infection and Immunity
|February 1, 1971
PubMed

Insights

Murine cytomegalovirus (MCMV) passage in cell culture attenuates its virulence in mice. This attenuated MCMV selectively infects organs, is a poor immunogen, but still protects against wild MCMV infection.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Murine cytomegalovirus (MCMV) is a common pathogen with significant virulence in mice.
  • Understanding MCMV attenuation is crucial for developing safer viral vectors and vaccines.

Purpose of the Study:

  • To investigate the effects of serial passage in mouse embryo cell culture on MCMV virulence and immunogenicity.
  • To characterize the biological and immunological properties of attenuated MCMV strains.

Main Methods:

  • Serial passage of MCMV in mouse embryo cell culture.
  • Assessment of viral lethality and organ-specific replication in suckling and weanling mice.
  • Evaluation of immune responses (antibody and interferon) and protection against wild-type MCMV challenge.

Main Results:

  • Passage rapidly attenuated MCMV, reducing lethality and replication in liver and spleen but not submaxillary glands or pancreas.
  • Attenuated MCMV failed to induce transient immune suppression seen with wild-type MCMV.
  • Both wild-type and attenuated MCMV were poor immunogens, inducing slow antibody responses.
  • Attenuated MCMV conferred full protection against lethal wild-type MCMV challenge, with virulence restored upon back passage in mice.

Conclusions:

  • Serial cell culture passage effectively attenuates MCMV virulence while maintaining selective organ tropism.
  • Attenuated MCMV represents a potentially valuable tool, demonstrating protective immunity without causing significant immune suppression.
  • Further research into MCMV attenuation mechanisms could inform vaccine development and gene therapy applications.